21.   In the present study, we could not detect a significant difference in orocaecal transit time between patients with and patients without cardiovascular autonomic neuropathy.

22.   Colonic transit time was significantly longer in the patients with cardiovascular autonomic neuropathy.

23.   Information concerning motility of the entire colon has been obtained by indirect measures such as the movement of radioopaque markers or barium to assess colonic transit time.

24.   The transit time in these patients was accelerated by a laxative, metoclopramide, and colonic lavage.

25.   It shows that where transit time is accelerated higher mucosal concentrations occur after slow release preparations than after azo-bound drugs.

26.   In contrast, Rijk et al evaluated the faecal excretions of healthy volunteers with accelerated transit time after a single dose.

27.   Transit time was not measured but it would be expected to be shorter.

28.   Whole gut transit time and daily stool weight were also measured.

29.   Faecal weights and transit times were not different between study periods.

30.   Transit times were determined using a multiple dose marker technique.